Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The Phase 2 trial reference point The Phase 2 retatrutide trial (Jastreboff et al., New England Journal of Medicine 2023) enrolled 338 adults across placebo and retatrutide arms at 1, 4, 8, and 12 mg weekly
The compound cannot be misbranded, mislabeled or misused for non-research purposes under any circumstances
In the rapidly evolving field of pharmaceutical research, two compounds have recently garnered significant attention: SLU-PP-332 and 5-amino-1mq
Given the unlicensed status of retatrutide in the UK and the complexity of injectable peptide reconstitution, seeking qualified medical advice before any use is strongly recommended and in many circumstances, essential
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
